国际眼科杂志Issue(2)：228-232,5.DOI:10.3980/j.issn.1672-5123.2015.2.11
糖尿病黄斑水肿的危险因素和药物治疗现状
Risk factors and the current pharmacotherapy situation of diabetic macular edema
摘要
Abstract
Diabetic retinopathy ( DR ) due to disturbance of carbohydrate metabolism is the most serious ocular complication in patients with diabetic disease, and diabetic macular edema ( DME) is one of the main causes of vision loss. lt is considered that many factors are involved in DME pathological process. DME is defined as an abnormal thickening of the macular associated with the accumulation of excess fluid in the extracellular space of the neurosensory retina. Nowadays, the main treatment methods of DME include pharmacotherapy, laser photocoagulation and surgery. lnflammatory components within the vascular tissue play an important role in the development of DME, so drug therapy is an important method for DME. ln this review, we summarized the risk factors and the current pharmacotherapy situation of DME.关键词
危险因素/糖尿病黄斑水肿/药物治疗Key words
risk factors/diabetic macular edema/pharmacotherapy引用本文复制引用
蔡蕾,徐国兴..糖尿病黄斑水肿的危险因素和药物治疗现状[J].国际眼科杂志,2015,(2):228-232,5.基金项目
国家自然科学基金(No.81271026) （No.81271026）
福建省创新平台基金(No.2010Y2003)@@@@National Natural Science Foundation of China ( No.81271026) （No.2010Y2003）
Innovative Platform Foundation of Fujian Province, China (No.2010Y2003) （No.2010Y2003）
